PPARG and type 2 diabetes mellitus: Pioglitazone (PZ) is a drug used to treat type 2 diabetes by enhancing insulin sensitivity [10], acting as an agonist of peroxisome proliferator-activated receptor gamma (PPAR-γ), a nuclear receptor that regulates glucose homeostasis, lipid metabolism, and inflammation [11].